S tent placement has effectively expanded the indications of endovascular treatment (EVT) for intracranial aneurysms. Low-profile endovascular devices enable access to aneurysms farther out in small cerebral arteries measuring < 2 mm in diameter.3,10,13 A very recent novel neurovascular self-expanding retrievable closedcell stent system, the LVIS (Low-Profile Visualized Intraluminal Stent) (MicroVention), can be delivered using the currently lowest-profile microcatheter.11 The LVIS Jr., which has a diameter of 2.5 mm, can be delivered and deployed in small distal arteries via a 0.017-in microcatheter. Thus, surgeons have recently been using the LVIS Jr. in small cerebral arteries. In the Republic of Korea, the LVIS and LVIS Jr. are not currently available. However, stents are still needed for use in small distal arteries to treat intracranial aneurysms. The self-expanding closedcell Enterprise stent (Codman Neurovascular), a low-profile endovascular device, is available in our country. It is delivered via a 0.021-in microcatheter and has been proposed for use in wide-necked, intracranial, and saccular abbreviatioNs DSA = digital subtraction angiography; EVT = endovascular treatment; GOS = Glasgow Outcome Scale; LVIS = Low-Profile Visualized Intraluminal Stent. submitted February 25, 2014. accepted November 6, 2014. iNclude wheN citiNg Published online January 2, 2015; DOI: 10.3171/2014.11.JNS14435. disclosure The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. The following grant funded this study: a new faculty research seed money grant from Yonsei University College of Medicine (2014-32-0029 obJect The purpose of this study was to report the authors' preliminary experience using self-expanding closed-cell stents deployed in small arteries (< 2 mm in diameter) to treat intracranial aneurysms. methods A total of 31 patients were studied. All subjects met the following criteria: 1) they received an Enterprise stent for treatment of a wide-necked aneurysm or a dissecting aneurysm or as part of a stent-salvage procedure; and 2) they had an Enterprise stent deployed in a small parent artery (< 2 mm in diameter) that had no atherosclerotic stenosis. Procedure-related complications and follow-up sizes of the parent arteries were evaluated for safety and patency. results There were 16 ruptured aneurysms and 15 unruptured aneurysms. Three (9.7%) of the 31 patients experienced procedure-related complications, and they all were asymptomatic. Follow-up angiography was performed in 27 patients (87.1%) (at a mean 15.5 months after surgery). Parent arteries with 2 acute angles (n = 4) were occluded in 3 cases (75.0%), and those with no acute angles (n = 13) or 1 acute angle (n = 6) showed 100% patency on follow-up angiography. There was a significant difference between the follow-up sizes (mean 1.72 ± 0.30 mm) of parent arteries and their sizes (mean 1.59 ± 0.26 mm) before treatment (95% CI -0.254 to -0.009 mm; p = 0.037, paired-samples t-t...